Pneumonia Therapeutics Market Insights and Development Trends 2021-2029: Abbott Laboratories, Allergan, AstraZeneca, Bayer

Pneumonia Therapeutics Market Snapshot:

The global pneumonia therapeutics market was valued at USD 1700 million in 2019 and is expected to grow at 7.8% CAGR during the forecast period. Pneumonia is a prevalent form of an acute respiratory infection that affects the alveoli of the lungs. Fungi, bacteria cause the disease, or viruses mediated infection. When an individual has pneumonia, the clinical manifestations can be as severe as painful breathing and oxygen deficiency due to limited intake for the patients; the alveolar sacs are filled with pus and fluid and chest pain, dry cough, and fever. In some instances, the disease can be as severe as fatal for patients.

The growing prevalence of pneumonia has been a significant driver of the pneumonia therapeutics market. Pneumonia is the biggest cause of mortality owing to an infectious disease in children worldwide. For instance, according to reports of the World Health Organization, pneumonia can be held accountable for 808 694 deaths under the age of 5 in 2017, which corresponds to 15% of all children's deaths within the age bracket. Further, as per the American thoracic society, considering the U.S., pneumonia can be held responsible for the most common cause of hospital admissions other than pregnancy. Statistically, it can be estimated that about 1 million adults in the U.S. seek medical care due to pneumonia annually, and further, 50,000 die from it. Thus, owing to such high prevalence, there is a massive demand for appropriate therapeutics in the market. This is boosting the global market significantly.
Additionally, as per the Center for Disease Control and Prevention (CDC), mortality due to pneumonia is astonishingly high at 14.7 deaths reported per 100,000 population. Thus, this increases the demand for therapeutic products from the market as due to high mortality, the management of the diseases becomes significantly essential. These factors influence market growth directly.

The high severity of pneumonia, coupled with high demand from the market, has boosted the R&D of new therapeutics and vaccines for addressing pneumonia. Further, this has resulted in propelling market growth projectile. For instance, at present, different companies operating in the pneumonia therapeutics market, which includes market giants like Merck, Pfizer, and GSK, are channelizing huge capital and putting enormous efforts in such R&D activities. This is further supported by successful clinical trials and regulatory approvals from concerned authorities. For instance, in February 2020, the U.S. FDA accepted a supplemental new drug application for Recarbrio to treat adults with ventilator-associated and hospital-acquired bacterial pneumonia. Thus, the introduction of such new drug molecules and support and approval from regulatory bodies augment market growth over the forecast period.

The online pharmacy segment is expected to witness a boost during the forecast period. This is owing to the recent boom in the e-commerce business across the globe during the COVID-19 pandemic. Further, online pharmacies' significant advantages have also played a major beneficial role in the segmental market. For example, online pharmacies offer products at a reasonable and cheaper price than offline stores, the unavailability of products is not an issue in the online medium, and very less additional cost are significant benefits of the segment.

The therapeutic drugs have majorly opted means of treatment for pneumonia infection. Therapeutic drugs include penicillin, cephalosporins, fluoroquinolones, tetracyclines, amoxicillin, vancomycin, and clavulanic acid. For instance, penicillin is a very widely used antibiotic to treat pneumonia caused by Pneumococcal pneumonia infection. Moreover, antibacterial drugs such as Macrolide, Quinolones are also used prevalently. Further, according to the American Thoracic Society 2019, viral pneumonia is one of the major causes of infants' hospitalization in the world. Thus, the rising prevalence of viral pneumonia drives the demand for antiviral therapeutics drugs. However, the drugs segment is anticipated to keep its large market share owing to an estimated steady growth during the forecast period. This can be attributed to the growing generic drugs industry that is contributing to the market. Further, recent patent exposures of branded drugs and the cost-effectiveness of generics are major factors that add to the market's advantage. 

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/pneumonia-therapeutics-market/request-sample

The Major Prominent Players Covered in this Report:
Abbott Laboratories
Allergan
AstraZeneca
Bayer
Cipla
GlaxoSmithKline Plc.
Lupin Pharmaceuticals Ltd.
Merck
Mylan
Novartis AG
Pfizer, Inc.

By Drug Class
Vaccines
Therapeutic Drugs
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Others

By Age Group
Pediatric
Adult
Geriatric

By Mode of Infection
Hospital-acquired pneumonia (HAP)
Community-acquired pneumonia (CAP)
Ventilator-associated pneumonia (VAP)

By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Pneumonia Therapeutics in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Pneumonia Therapeutics market during the forecast period 2021-2029. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Pneumonia Therapeutics and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Pneumonia Therapeutics. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/pneumonia-therapeutics-market/

Key Questions Answered in The Report:
What will the Pneumonia Therapeutics market growth rate?
What are the key factors driving the global Pneumonia Therapeutics market?
Who are the key manufacturers in the Pneumonia Therapeutics market space?
What are the market opportunities, market risk, and market overview of the Pneumonia Therapeutics market?
What are sales, revenue, and price analysis of top manufacturers of the Pneumonia Therapeutics market?
Who are the distributors, traders, and dealers of the Pneumonia Therapeutics market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Pneumonia Therapeutics Industry?
What are sales, revenue, and price analysis by regions of Pneumonia Therapeutics industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Key Pneumonia Therapeutics Market Trends:
- The report identifies, determines, and forecasts the Global Pneumonia Therapeutics Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Pneumonia Therapeutics Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Pneumonia Therapeutics Market.

Browse Full Report @ 
https://straitsresearch.com/report/pneumonia-therapeutics-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/report/pneumonia-therapeutics-market/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs.

This release was published on openPR.